CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus Inc. (NASDAQ: ZLCS) a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced that Justin Renz, Senior Vice President and CFO is scheduled to present at the Wall Street Analyst Forum’s 21st Annual Analyst Conference at 9:50 a.m. ET on November 11, 2010, at the University Club, 1 West 54th Street, New York. Interested parties may attend the Zalicus presentation in-person by registering in advance on www.analyst-conference.com (the University Club adheres to a business attire only dress code). The presentation may also be accessed on-line by visiting the Zalicus website at www.zalicus.com or through the provider’s website http://www.wsw.com/webcast/wsaf17/zlcs. The webcast will be archived on the Zalicus website following the event.
